Line 2: |
Line 2: |
| <multilang> | | <multilang> |
| @en|__NOTOC__ | | @en|__NOTOC__ |
− | <div style='color: black; padding: 3px; text-align:right; font: arial;'>This page was modified on 2020/07/21 12:03</div> | + | <div style='color: black; padding: 3px; text-align:right; font: arial;'>This page was modified on 2020/07/21 18:02</div> |
| <h2>Thursday, July 30, 2020</h2> | | <h2>Thursday, July 30, 2020</h2> |
| <table class='wikitable sortable nowrap' style='width:100%'> | | <table class='wikitable sortable nowrap' style='width:100%'> |
Line 16: |
Line 16: |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>TBS - Payrules (Emerging Tech)</td>
| + | <td style='width:50%'>SSC - CASB Pilot Architecture</td> |
− | <td style='width:25%'>TBS</td>
| |
− | <td style='width:25%'>Endorsement</td>
| |
− | </tr>
| |
− | <tr>
| |
− | <td style='width:50%'>SSC - CASB</td> | |
| <td style='width:25%'>SSC</td> | | <td style='width:25%'>SSC</td> |
| <td style='width:25%'>Endorsement</td> | | <td style='width:25%'>Endorsement</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>CSC - Pharmacy Management System</td> | + | <td style='width:50%'>CSC - Regional Pharmacy Management Solution</td> |
| <td style='width:25%'>CSC</td> | | <td style='width:25%'>CSC</td> |
| <td style='width:25%'>Endorsement</td> | | <td style='width:25%'>Endorsement</td> |
Line 36: |
Line 31: |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>Multi-Dept - Cumulative Effects and Impact Assessments Registries - Follow-up (IAAC/TC/NRCan/DFO )</td> | + | <td style='width:50%'>TBS - Changes to the GC Cloud Guardrails Process</td> |
− | <td style='width:25%'>CEAA;DFO;TC;Multi;iaac;nrcan</td> | + | <td style='width:25%'>TBS</td> |
− | <td style='width:25%'>Information</td> | + | <td style='width:25%'>Endorsement</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>TBS - Changes to the GC Cloud Guardrails Process</td> | + | <td style='width:50%'>TBS - Payrules (Emerging Tech)</td> |
| <td style='width:25%'>TBS</td> | | <td style='width:25%'>TBS</td> |
| <td style='width:25%'>Endorsement</td> | | <td style='width:25%'>Endorsement</td> |
Line 62: |
Line 57: |
| <td style='width:50%'>Opening Remarks</td> | | <td style='width:50%'>Opening Remarks</td> |
| <td style='width:25%'>TBS;SSC</td> | | <td style='width:25%'>TBS;SSC</td> |
| + | <td style='width:25%'>Information</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>Multi-Dept - Cumulative Effects and Impact Assessments Registries - Follow-up (IAAC/TC/NRCan/DFO )</td> |
| + | <td style='width:25%'>CEAA;DFO;TC;Multi;iaac;nrcan</td> |
| <td style='width:25%'>Information</td> | | <td style='width:25%'>Information</td> |
| </tr> | | </tr> |
Line 313: |
Line 313: |
| <br/> | | <br/> |
| @fr|__NOTOC__ | | @fr|__NOTOC__ |
− | <div style='color: black; padding: 3px; text-align:right; font: arial;'>Cette page a été modifiée le 2019-12-01 2020/07/21 12:03</div> | + | <div style='color: black; padding: 3px; text-align:right; font: arial;'>Cette page a été modifiée le 2019-12-01 2020/07/21 18:02</div> |
| <h2>30 juillet 2020</h2> | | <h2>30 juillet 2020</h2> |
| <table class='wikitable sortable nowrap' style='width:100%'> | | <table class='wikitable sortable nowrap' style='width:100%'> |
Line 327: |
Line 327: |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>TBS - Payrules (Emerging Tech)</td>
| + | <td style='width:50%'>SSC - CASB Pilot Architecture</td> |
− | <td style='width:25%'>TBS</td>
| |
− | <td style='width:25%'>Approbation</td>
| |
− | </tr>
| |
− | <tr>
| |
− | <td style='width:50%'>SSC - CASB</td> | |
| <td style='width:25%'>SSC</td> | | <td style='width:25%'>SSC</td> |
| <td style='width:25%'>Approbation</td> | | <td style='width:25%'>Approbation</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>CSC - Pharmacy Management System</td> | + | <td style='width:50%'>CSC - Regional Pharmacy Management Solution</td> |
| <td style='width:25%'>CSC</td> | | <td style='width:25%'>CSC</td> |
| <td style='width:25%'>Approbation</td> | | <td style='width:25%'>Approbation</td> |
Line 347: |
Line 342: |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>Multi-Dept - Cumulative Effects and Impact Assessments Registries - Follow-up (IAAC/TC/NRCan/DFO )</td> | + | <td style='width:50%'>TBS - Changes to the GC Cloud Guardrails Process</td> |
− | <td style='width:25%'>CEAA;DFO;TC;Multi;iaac;nrcan</td> | + | <td style='width:25%'>TBS</td> |
− | <td style='width:25%'>Information</td> | + | <td style='width:25%'>Approbation</td> |
| </tr> | | </tr> |
| <tr> | | <tr> |
− | <td style='width:50%'>TBS - Changes to the GC Cloud Guardrails Process</td> | + | <td style='width:50%'>TBS - Payrules (Emerging Tech)</td> |
| <td style='width:25%'>TBS</td> | | <td style='width:25%'>TBS</td> |
| <td style='width:25%'>Approbation</td> | | <td style='width:25%'>Approbation</td> |
Line 373: |
Line 368: |
| <td style='width:50%'>Opening Remarks</td> | | <td style='width:50%'>Opening Remarks</td> |
| <td style='width:25%'>TBS;SSC</td> | | <td style='width:25%'>TBS;SSC</td> |
| + | <td style='width:25%'>Information</td> |
| + | </tr> |
| + | <tr> |
| + | <td style='width:50%'>Multi-Dept - Cumulative Effects and Impact Assessments Registries - Follow-up (IAAC/TC/NRCan/DFO )</td> |
| + | <td style='width:25%'>CEAA;DFO;TC;Multi;iaac;nrcan</td> |
| <td style='width:25%'>Information</td> | | <td style='width:25%'>Information</td> |
| </tr> | | </tr> |